Basilea Pharmaceutica AG (SWX:BSLN)

Basilea Pharmaceutica AG Statistics

Total Valuation

SWX:BSLN has a market cap or net worth of CHF 602.71 million. The enterprise value is 571.13 million.

Market Cap	602.71M
Enterprise Value	571.13M

Important Dates

The next estimated earnings date is Tuesday, February 17, 2026.

Earnings Date	Feb 17, 2026
Ex-Dividend Date	n/a

Share Statistics

SWX:BSLN has 12.29 million shares outstanding. The number of shares has increased by 15.14% in one year.

Current Share Class	12.29M
Shares Outstanding	12.29M
Shares Change (YoY)	+15.14%
Shares Change (QoQ)	-0.29%
Owned by Insiders (%)	0.27%
Owned by Institutions (%)	34.07%
Float	12.25M

Valuation Ratios

The trailing PE ratio is 8.96 and the forward PE ratio is 12.86.

PE Ratio	8.96
Forward PE	12.86
PS Ratio	2.55
PB Ratio	5.84
P/TBV Ratio	5.86
P/FCF Ratio	7.73
P/OCF Ratio	7.58
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.12, with an EV/FCF ratio of 7.33.

EV / Earnings	7.86
EV / Sales	2.42
EV / EBITDA	7.12
EV / EBIT	7.46
EV / FCF	7.33

Financial Position

The company has a current ratio of 6.32, with a Debt / Equity ratio of 0.94.

Current Ratio	6.32
Quick Ratio	5.40
Debt / Equity	0.94
Debt / EBITDA	1.21
Debt / FCF	1.24
Interest Coverage	20.43

Financial Efficiency

Return on equity (ROE) is 121.16% and return on invested capital (ROIC) is 29.07%.

Return on Equity (ROE)	121.16%
Return on Assets (ROA)	21.88%
Return on Invested Capital (ROIC)	29.07%
Return on Capital Employed (ROCE)	35.70%
Revenue Per Employee	1.31M
Profits Per Employee	403,656
Employee Count	164
Asset Turnover	1.08
Inventory Turnover	4.69

Taxes

Income Tax	-378,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +20.07% in the last 52 weeks. The beta is 0.43, so SWX:BSLN's price volatility has been lower than the market average.

Beta (5Y)	0.43
52-Week Price Change	+20.07%
50-Day Moving Average	47.49
200-Day Moving Average	47.30
Relative Strength Index (RSI)	64.14
Average Volume (20 Days)	30,873

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SWX:BSLN had revenue of CHF 236.21 million and earned 72.66 million in profits. Earnings per share was 5.47.

Revenue	236.21M
Gross Profit	109.58M
Operating Income	76.57M
Pretax Income	72.28M
Net Income	72.66M
EBITDA	78.07M
EBIT	76.57M
Earnings Per Share (EPS)	5.47

Balance Sheet

The company has 128.37 million in cash and 96.79 million in debt, giving a net cash position of 31.58 million or 2.57 per share.

Cash & Cash Equivalents	128.37M
Total Debt	96.79M
Net Cash	31.58M
Net Cash Per Share	2.57
Equity (Book Value)	103.16M
Book Value Per Share	8.40
Working Capital	183.07M

Cash Flow

In the last 12 months, operating cash flow was 79.50 million and capital expenditures -1.56 million, giving a free cash flow of 77.94 million.

Operating Cash Flow	79.50M
Capital Expenditures	-1.56M
Free Cash Flow	77.94M
FCF Per Share	6.34

Margins

Gross margin is 46.39%, with operating and profit margins of 32.41% and 30.76%.

Gross Margin	46.39%
Operating Margin	32.41%
Pretax Margin	30.60%
Profit Margin	30.76%
EBITDA Margin	33.05%
EBIT Margin	32.41%
FCF Margin	32.99%

Dividends & Yields

SWX:BSLN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.14%
Shareholder Yield	-15.14%
Earnings Yield	12.06%
FCF Yield	12.93%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SWX:BSLN has an Altman Z-Score of -0.09 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.09
Piotroski F-Score	8